Claudia Adrien

Senior Correspondent

"Claudia Adrien is a journalist who writes about personalized nutrition, longevity, the microbiome, supplements and how the science, business and legal aspects of these industries coincide. She was the first reporter to break news that personalized vitamin company Care/of had been shuttered by its parent company Bayer just four years after the multinational giant purchased the startup for $225 million. Prior to NutraIngredients, Claudia worked for a tech publication covering companies such as Amazon (AWS), Microsoft, Google, Zoom, Cisco and Nvidia. Over the last two decades, she has reported on a variety of topics including artificial intelligence, bioterrorism, climate change, infectious disease spread and the international coffee trade. Claudia’s work has appeared in Newsweek, Science Daily, the Discovery Channel, Deutsche Welle, Current TV, Homeland Preparedness News, the Express Tribune with the International New York Times, and regional Florida newspapers. Her work has been cited in books on sociology, history and the environment. "

All stories

Longevity investors: Money is expensive, science and roadmaps matter

Longevity investors: Money is expensive, science and roadmaps matter

By Claudia Adrien

While the financing environment in the healthspan and longevity sector may not be as hospitable as it once was during initial hype-peak years, there are signals that money is still available for companies with strong science, realistic plans and...